The positive thrust on research and innovation is a welcome move to take India to the next level. The emphasis on healthcare is a significant step for India’s overall development given its demographic profile," stated Sudarshan Jain.

Sudarshan Jain added that the Government has announced further strengthening healthcare infrastructure with a focus on increasing Nursing Colleges, Artificial Intelligence, Digital Skilling and Sickle Cell Anaemia Elimination Mission.

Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance stated that Indian pharmaceutical industry is a knowledge-driven sector with R&D being core to the growth. 

"The Union Budget 2023 aims to provide stimulus towards innovation with the announcement of the promotion of research and innovation programme in pharmaceuticals through Centres of Excellence. In FY23, the healthcare expenditure on GDP has gone up to 2.1% from 1.4% in FY19. The Government has announced further strengthening healthcare infrastructure with a focus on increasing Nursing Colleges, Artificial Intelligence, Digital Skilling and Sickle Cell Anaemia Elimination Mission. The positive thrust on research and innovation is a welcome move to take India to the next level. The emphasis on healthcare is a significant step for India’s overall development given its demographic profile," stated Sudarshan Jain.